AIDS and Behavior

, 13:1189

One Year After ART Initiation: Psychosocial Factors Associated with Stigma Among HIV-Positive Mozambicans

  • C. R. Pearson
  • M. A. Micek
  • J. Pfeiffer
  • P. Montoya
  • E. Matediane
  • T. Jonasse
  • A. Cunguara
  • D. Rao
  • S. S. Gloyd
Original Paper

Abstract

The pathways through which stigma is associated with psychological distress remains understudied in Africa. This study evaluates stigma among 277 Mozambicans who were on an antiretroviral therapy (ART) regimens for a full year. Using bivariate and multiple regression analyses, we examine psychosocial factors (disclosure decisions, perceived social support, and depression) associated with stigma, at ART initiation and 1 year later. We found 1 year after initiating ART, participants reported no change in stigma, a decrease in perceived social support, and an increase in depressive symptomology. Disclosing HIV status to friends (versus family or partner) was associated with lower levels of stigma. These findings suggest that HIV care in comparable settings should include counselling, support groups, and peer support, that includes stigma and disclosure concerns prior to and during the first year following diagnosis. Most importantly, assessment and treatment of depression should be incorporated into ongoing HIV care.

Keywords

Stigma Disclosure HIV/AIDS Africa Depression 

References

  1. 1.
    Holzemer WL, Uys LR. Managing AIDS stigma. Sahara J. 2004;1(3):165–74.PubMedGoogle Scholar
  2. 2.
    MISAU. Demographic impact of HIV/AIDS in Mozambique: update from the 2007 epidemiological surveillance round Maputo. Mozambique: Mozambique Ministry of Health; 2008.Google Scholar
  3. 3.
    MISAU. National ART Data. Maputo, Mozambique: available at Mozambique Ministry of Health (MISAU) website. 2009. (http://www.misau.gov.mz/pt/hiv_sida/programa_de_tratamento_antiretroviral_tarv/dados_tarv_nacionais). Accessed 17 March 2009.
  4. 4.
    Micek MA, Baptista A, Ferro J, Melo A, Gimbel-Sherr K, Gimbel-Sherr S, et al., editors. Evaluating the flow of adults in public HIV care systems in Mozambique: identifying obstacles to care. Oral presentation at: The 17th International AIDS Conference; August 3–8; Mexico City; 2008.Google Scholar
  5. 5.
    Yang L, Kleinman A, Link B, Phelan J, Lee S, Good B. Culture and stigma: adding moral experience to stigma theory. Soc Sci Med. 2007;64(7):1524–35.CrossRefPubMedGoogle Scholar
  6. 6.
    Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13–24.CrossRefPubMedGoogle Scholar
  7. 7.
    Corrigan P, Watson A. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13–24.CrossRefGoogle Scholar
  8. 8.
    Nyblade LC. Measuring HIV stigma: existing knowledge and gaps. Psychol Health Med. 2006;11(3):335–45.CrossRefPubMedGoogle Scholar
  9. 9.
    Pulerwitz J, Michaelis AP, Lippman SA, Chinaglia M, Diaz J. HIV-related stigma, service utilization, and status disclosure among truck drivers crossing the Southern borders in Brazil. AIDS Care. 2008;20(2):198–204.CrossRefGoogle Scholar
  10. 10.
    Hutchinson PL, Mahlalela X. Utilization of voluntary counseling and testing services in the Eastern Cape, South Africa. AIDS Care. 2006;18(5):446–55.CrossRefPubMedGoogle Scholar
  11. 11.
    Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28–33.CrossRefPubMedGoogle Scholar
  12. 12.
    Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDs. 2006;20(5):359–68.CrossRefPubMedGoogle Scholar
  13. 13.
    Ware NC, Wyatt MA, Tugenberg T, Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006;18(8):904–10. [Research Support, N.I.H., Extramural].CrossRefPubMedGoogle Scholar
  14. 14.
    Sikkema K, Kalichman S, Hoffmann R, Koob J, Kelly J, Heckman T. Coping strategies and emotional well-being among HIV-infected men and women experiencing AIDS-related bereavement. AIDS Care. 2000;12(5):613–24.CrossRefPubMedGoogle Scholar
  15. 15.
    Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Raue P, Friedman SJ, et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. AIDS Care. 2001;158(3):479–81.Google Scholar
  16. 16.
    DiIorio C, McCarty F, Depadilla L, Resnicow K, Holstad MM, Yeager K. Adherence to antiretroviral medication regimens: a test of a psychosocial model. AIDS Behav. 2007;3:3.Google Scholar
  17. 17.
    Purcell DW, Latka MH, Metsch LR, Latkin CA, Gomez CA, Mizuno Y, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007;46(Suppl 2):S35–47.PubMedGoogle Scholar
  18. 18.
    Holzemer WL, Uys L, Makoae L, Stewart A, Phetlhu R, Dlamini PS, et al. A conceptual model of HIV/AIDS stigma from five African countries. J Adv Nurs. 2007;58(6):541–51.CrossRefPubMedGoogle Scholar
  19. 19.
    NIH. Panel on clinical practices for treatment of HIV. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Atlanta: Centers for Diseases Control and Prevention; 2002.Google Scholar
  20. 20.
    Remien RH, Bastos FI, Jnr VT, Raxach JC, Pinto RM, Parker RG, et al. Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil. AIDS Care. 2007;19(6):740–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Godin G, Côté J, Naccache H, Lambert LD, Trottier S. Prediction of adherence to antiretroviral therapy: a one-year longitudinal study. AIDS Care. 2005;17(4):493–504.PubMedGoogle Scholar
  22. 22.
    Adedayo A, Modupeola A, Timothy A, editors. Scaling up antiretroviral therapy use for HIV-positive adults in southwestern Nigeria. 12th Conference on Retroviruses and Opportunistic Infections; 2005 February 22–25; Boston; 2005.Google Scholar
  23. 23.
    Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retrovir. 2004;20(10):1053–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Health and Development Networks. Stigma, HIV/AIDS, and disclosure: summary of stigma-AIDS eForum discussion. Chiang Mai: Health and Development Networks; 2006.Google Scholar
  25. 25.
    Lee SJ, Detels R, Rotheram-Borus MJ, Duan N, Lord L. Depression and social support among HIV-affected adolescents. AIDS Patient Care STDS. 2007;21(6):409–17.CrossRefPubMedGoogle Scholar
  26. 26.
    McDowell TL, Serovich JM. The effect of perceived and actual social support on the mental health of HIV-positive persons. AIDS Care. 2007;19(10):1223–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Golub SA, Tomassilli JC, Parsons JT. Partner serostatus and disclosure stigma: implications for physical and mental health outcomes among HIV-positive adults. AIDS Behav. 2008;9:9.Google Scholar
  28. 28.
    Paxton S. The paradox of public HIV disclosure. AIDS Care. 2002;14(4):559–69.PubMedGoogle Scholar
  29. 29.
    Antelman G, Fawzi MS, Kaaya S, Mbwambo J, Msamanga G, Hunter D, et al. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es-Salaam, Tanzania. AIDS. 2001;15(14):1865–74.CrossRefPubMedGoogle Scholar
  30. 30.
    Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.PubMedGoogle Scholar
  31. 31.
    Pearson CR, Micek MA, Simoni JM, Hoff PD, Matediana E, Martin DP, et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr. 2007;46(2):238–44.CrossRefPubMedGoogle Scholar
  32. 32.
    Pearson CR, Micek M, Simoni JM, Matediana E, Martin DP, Gloyd S. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S134–41.PubMedGoogle Scholar
  33. 33.
    Pearson CR, Simoni JM, Gloyd SS. Evaluation of a Portuguese-version of psychsocial measures in a study of adherence to HAART in Mozambique. Society for Behavioral Medicine 27th Annual Meeting and Scientific Sessions; March 22–25; San Francisco; 2006.Google Scholar
  34. 34.
    Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–29.CrossRefPubMedGoogle Scholar
  35. 35.
    Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–29.CrossRefPubMedGoogle Scholar
  36. 36.
    Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17(10):756–65.CrossRefPubMedGoogle Scholar
  37. 37.
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRefGoogle Scholar
  38. 38.
    Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10:77–84.PubMedGoogle Scholar
  39. 39.
    Kulik JA, Mahler HIM. Emotional support as a moderator of adjustment and compliance after coronary artery bypass surgery: a longitudinal study. J Behav Med. 1993;12:56–63.Google Scholar
  40. 40.
    Murphy DA, Greenwell L, Hoffman D. Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health. 1993;36(1):97–111.Google Scholar
  41. 41.
    Baum CB. An introduction to modern econometrics using Stata College Station. Texas: STATA Press; 2006.Google Scholar
  42. 42.
    Emlet CA. A comparison of HIV stigma and disclosure patterns between older and younger adults living with HIV/AIDS. AIDS Patient Care STDs. 2006;20(350):358.Google Scholar
  43. 43.
    Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one’s HIV-positive status, stigma and social support. AIDS Care. 2008;17:1–10.Google Scholar
  44. 44.
    Dlamini P, Kohi T, Uys L, Phetlhu R, Chirwa M, Naidoo J, et al. Verbal and physical abuse and neglect as manifestations of HIV/AIDS stigma in five African countries. Public Health Nurs. 2007;24(5):389–99.CrossRefPubMedGoogle Scholar
  45. 45.
    Kalichman SC, Klein SJ, Kalichman MO, O’Connell DA, Freedman JA, Eaton L, et al. HIV/AIDS case managers and client HIV status disclosure: perceived client needs, practices, and services. Health Soc Work. 2007;32(4):259–67.PubMedGoogle Scholar
  46. 46.
    Tarwireyi F. Stigma and discrimination: coping behaviours of people living with HIV and AIDS in an urban community of Mabvuku and Tafara, Harare, Zimbabwe. Cent Afr J Med. 2005;51(7–8):71–6.PubMedGoogle Scholar
  47. 47.
    Fulk LJ, Kane BE, Phillips KD, Bopp CM, Hand GA. Depression in HIV-infected patients: allopathic, complementary, and alternative treatments. J Psychosom Res. 2004;57(4):339–51.PubMedGoogle Scholar
  48. 48.
    Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38(4):432–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Laperriere A, Ironson GH, Antoni MH, Pomm H, Jones D, Ishii M, et al. Decreased depression up to one year following CBSM+ intervention in depressed women with AIDS: the smart/EST women’s project. J Health Psychol. 2005;10(2):223–31.CrossRefPubMedGoogle Scholar
  50. 50.
    Rousaud A, Blanch J, Hautzinger M, De Lazzari E, Peri JM, Puig O, et al. Improvement of psychosocial adjustment to HIV-1 infection through a cognitive-behavioral oriented group psychotherapy program: a pilot study. AIDS Patient Care STDS. 2007;21(3):212–22.CrossRefPubMedGoogle Scholar
  51. 51.
    Balfour L, Kowal J, Silverman A, Tasca GA, Angel JB, Macpherson PA, et al. A randomized controlled psycho-education intervention trial: improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care. 2006;18(7):830–8.CrossRefPubMedGoogle Scholar
  52. 52.
    Olatunji BO, Mimiaga MJ, O’Cleirigh C, Safren SA. Review of treatment studies of depression in HIV. Top HIV Med. 2006;14(3):112–24.PubMedGoogle Scholar
  53. 53.
    Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26(4):488–95.CrossRefPubMedGoogle Scholar
  54. 54.
    Simbayi LC, Kalichman S, Strebel A, Cloete A, Henda N, Mqeketo A. Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town, South Africa. Soc Sci Med. 2007;64(9):1823–31. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t].CrossRefPubMedGoogle Scholar
  55. 55.
    Prachakul W, Grant J, Keltner N. Relationships among functional social support, HIV-related stigma, social problem solving, and depressive symptoms in people living with HIV: a pilot study. J Assoc Nurses AIDS Care. 2007;18(6):67–76.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • C. R. Pearson
    • 1
  • M. A. Micek
    • 2
  • J. Pfeiffer
    • 2
  • P. Montoya
    • 3
  • E. Matediane
    • 4
  • T. Jonasse
    • 3
  • A. Cunguara
    • 3
  • D. Rao
    • 5
  • S. S. Gloyd
    • 2
  1. 1.School of Social Work, Indigenous Wellness Research InstituteUniversity of WashingtonSeattleUSA
  2. 2.Department of Global HealthUniversity of WashingtonSeattleUSA
  3. 3.Health Alliance InternationalBeiraMozambique
  4. 4.Ministry of Health, MozambiqueBeiraMozambique
  5. 5.Department of Psychiatry and Behavioral SciencesNorthwestern UniversityChicagoUSA

Personalised recommendations